Jan 20, 2020
Serge Saxonov co-founded 10x Genomics in 2012 and has served as the CEO since its inception. He has defined the company's vision and strategy, contributed to core inventions, and led 10x through multiple phases of rapid growth. 10x Genomics is a leading company in the field of genomics. The company was founded on the vision that this century will bring unprecedented advances in biomedicine to transform the way we understand and treat diseases leading to dramatic improvements in human health.
In 2016, he was honored as one of Goldman Sachs 100 Most Intriguing Entrepreneurs of the Year. Prior to 10x Genomics, Serge was Vice President of Applications at QuantaLife, where he was responsible for building content, driving new applications, and identifying key diagnostics opportunities for the core ddPCR technology. Before QuantaLife, Serge was the first employee at 23andme. As Founding Architect and Director of R&D, he defined the initial conception of the product, recruited a lot of the earlier team and built many key elements of the technology. Serge received a Ph.D. in biomedical informatics from Stanford University and an A.B. in applied mathematics and biology from Harvard College.